iOrganBio Appoints Zhiping Pang, M.D., Ph.D., to Scientific Advisory Board

iOrganBio has appointed neurobiology expert Zhiping Pang to its Scientific Advisory Board, strengthening its leadership in AI-enabled human cell and organoid production for research and therapeutic applications.

NY Metrowire Staff
Business
iOrganBio Appoints Zhiping Pang, M.D., Ph.D., to Scientific Advisory Board

iOrganBio, an innovator in intelligent cell manufacturing, announced the appointment of Zhiping Pang, M.D., Ph.D., to its Scientific Advisory Board. Dr. Pang is a leading expert in human neuron biology, synaptic function, and the molecular mechanisms underlying neuropsychiatric and metabolic disorders. He is the Henry Rutgers Professor of NeuroMetabolism and Professor of Neuroscience and Cell Biology at Rutgers Robert Wood Johnson Medical School, and Director of the Center for NeuroMetabolism at Rutgers Health.

Dr. Pang brings extensive experience with over 140 publications in top journals including Nature, Science, Nature Neuroscience, and Nature Metabolism. His expertise will advise iOrganBio as the field moves toward more human-relevant, non-animal systems. This appointment bolsters iOrganBio's position as a leader in AI-enabled, scalable, human cell and organoid production.

iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core is iOrganBio's functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides digital blueprints for each cell type.

For more information, visit iOrgan.Bio.

Blockchain Registration

QR Code for Blockchain Registration